CureledgerCureledger

Blog

The case for patient-controlled rare disease data across science, policy, and the lived experience.

Featured

Patient Experience

What we still have to do

The structural friction of rare disease daily life.

Read →

This week

Data Sovereignty

Unpaid data farmers

The data work we have been doing for free, finally compensated.

Read →
Vision

The flywheel

Cohort proof licensed. Contribution measured. Deposit lands.

Read →
Science & Data

Cohort proofs

Privacy from cryptography. Validation without exposure.

Read →

Search articles

Browse by tag

Clear ×
Patient ExperienceData SovereigntyVisionScience & DataRegulatoryUltra-rareAccelerating innovationEhlers-DanlosNewborn screeningCompanyHistory
Read all14 of 116 · Tag: Ehlers-Danlos
  1. May 7, 2026The EDS diagnosis problem solves itself
  2. May 7, 2026The 14 EDS subtypes, in plain words
  3. May 7, 2026Vascular EDS, the dangerous subtype
  4. May 7, 2026Classical EDS, the original
  5. May 7, 2026Kyphoscoliotic EDS
  6. May 7, 2026Cardiac-valvular EDS
  7. May 7, 2026Dermatosparaxis EDS
  8. May 7, 2026The Beighton Score Problem
  9. May 7, 2026EDS and pregnancy
  10. May 7, 2026Lidocaine resistance and EDS
  11. May 7, 2026The Diagnostic Odyssey as Systems Failure
  12. May 7, 2026Three Specialists Who Don't Talk to Each Other
  13. Apr 28, 2026Serola SI belt, a daily-life spotlight
  14. Apr 28, 2026hEDS criteria 2017, for the newly diagnosed